CNTB
Connect Biopharma Holdings LtdCompany Information
- Company Name
- Connect Biopharma Holdings Ltd
- CIK
- CIK0001835268
- Category
- Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
- Ticker: Exchange
- CNTB: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- CNTB
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-05-29
- Last sale
- —
- Shares purchased (TTM)
- 1,310,000
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 13,893,689
- Shares outstanding
- 62,884,000
- Ownership
- 22.09%
Earnings Market Reaction
- Filing date
- 2026-08-12
- Price on filing date
- —
- 1-month reaction
- -21.03%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | |||||||||||||
| Cash And Cash Equivalents At Carrying Value | 27 | 46 | 38 | 38 | 41 | 48 | 78 | ||||||
| Short Term Investments | 4 | 0 | 6 | 17 | 31 | 36 | 15 | ||||||
| Accounts Receivable Net Current | 3 | 0 | 0 | 0 | 0 | 0 | 1 | ||||||
| Prepaid Expense And Other Assets Current | 4 | 9 | 7 | 8 | 6 | 4 | 2 | ||||||
| Assets Current | 39 | 55 | 51 | 63 | 78 | 88 | 97 | ||||||
| Property Plant And Equipment Net | 4 | 4 | 4 | 4 | 4 | 4 | 4 | ||||||
| Operating Lease Right Of Use Asset | 1 | 1 | 1 | 1 | 1 | 1 | 0 | ||||||
| Finite Lived Intangible Assets Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Other Assets Noncurrent | 1 | 1 | 1 | 0 | 0 | 0 | 0 | ||||||
| Assets | 43 | 60 | 56 | 67 | 83 | 93 | 101 | ||||||
Liabilities Current | |||||||||||||
| Accounts Payable Current | 2 | 4 | 2 | 2 | 2 | 1 | 0 | ||||||
| Accrued Liabilities Current | 14 | 12 | 11 | 9 | 8 | 7 | 8 | ||||||
| Contract With Customer Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities Current | 16 | 17 | 14 | 11 | 11 | 9 | 8 | ||||||
| Operating Lease Liability Noncurrent | 0 | 0 | 0 | 0 | 1 | 1 | 0 | ||||||
| Other Liabilities Noncurrent | 0 | 0 | 0 | 0 | 0 | 1 | 1 | ||||||
| Contract With Customer Liability Noncurrent | - | - | - | - | - | - | 1 | ||||||
| Liabilities | 17 | 17 | 14 | 12 | 11 | 10 | 9 | ||||||
Stockholders Equity | |||||||||||||
| Preferred Stock Value | - | - | 0 | - | - | - | 0 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 466 | 464 | 444 | 443 | 441 | 440 | 439 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -1 | -1 | -1 | -1 | -1 | -2 | -2 | ||||||
| Treasury Stock Common Value | -0 | -0 | -0 | -0 | -0 | -0 | -0 | ||||||
| Retained Earnings Accumulated Deficit | -438 | -420 | -401 | -386 | -369 | -356 | -345 | ||||||
| Stockholders Equity | 27 | 43 | 42 | 55 | 71 | 83 | 92 | ||||||
| Liabilities And Stockholders Equity | 43 | 60 | 56 | 67 | 83 | 93 | 101 | ||||||
| Preferred Stock Par Or Stated Value Per Share | - | - | 0.00 | - | - | - | 0.00 | ||||||
| Preferred Stock Shares Authorized | - | - | 40 | - | - | - | 40 | ||||||
| Preferred Stock Shares Issued | - | - | 0 | - | - | - | 0 | ||||||
| Preferred Stock Shares Outstanding | - | - | 0 | - | - | - | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 400 | 400 | 400 | 400 | 400 | 400 | 400 | ||||||
| Common Stock Shares Issued | 63 | 63 | 56 | 56 | 56 | 55 | 55 | ||||||
| Shares Outstanding | 63 | 63 | 56 | 56 | 56 | 55 | 55 | ||||||
Select a line item above to chart it.
Recent filings
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialConnect Biopharma Holdings Ltd (CNTB) — SEC Financial Statements & Analysis
Connect Biopharma Holdings Ltd (CNTB) is a pharmaceutical preparations company, incorporated in E9. Connect Biopharma Holdings Ltd trades on Nasdaq as: CNTB. Connect Biopharma Holdings Ltd (CNTB)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-12. Based on that filing, Connect Biopharma Holdings Ltd carries a market cap of $149.66M, a P/E ratio of -2.17x, a P/B ratio of 5.57x, a P/S ratio of 50.68x, an enterprise value of $122.65M, and an EV/EBITDA multiple of -1.76x. On profitability, it posts an operating margin of -2384.49%, a net margin of -2336.30%, a Return on Equity (ROE) of -140.51%, a Return on Assets (ROA) of -109.34%, and a Return on Invested Capital (ROIC) of -661.05%. Per share, it reports EPS of $-1.10, diluted EPS of $-1.10, free cash flow per share of $-0.96, and a dividend per share of $0.00. On the balance sheet, it maintains a current ratio of 2.37x, a quick ratio of 2.11x, working capital of $22.32M, a debt-to-equity ratio of 0.62x, a debt ratio of 0.38, free cash flow of $-60.63M (TTM), and net debt of $-27.02M. Figures sourced from SEC EDGAR.
- Market Cap
- $149.66M
- P/E TTM
- -2.17x
- EPS TTM
- $-1.10
- P/B TTM
- 5.57x
- ROE TTM
- -140.51%
- ROA TTM
- -109.34%
- Debt To Equity
- 0.62x
- Free Cash Flow TTM
- $-60.63M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Connect Biopharma Holdings Ltd in?
Connect Biopharma Holdings Ltd (CNTB) operates in the Pharmaceutical Preparations industry.
What exchange does CNTB trade on?
Connect Biopharma Holdings Ltd (CNTB) trades on the Nasdaq.
Where is Connect Biopharma Holdings Ltd incorporated?
Connect Biopharma Holdings Ltd is incorporated in Cayman Islands.
When was Connect Biopharma Holdings Ltd (CNTB)'s most recent SEC filing?
Connect Biopharma Holdings Ltd (CNTB)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-12.
What is CNTB's market cap?
Connect Biopharma Holdings Ltd (CNTB) has a market capitalization of $149.66M as of 2026-06-30.
What is CNTB's EPS (earnings per share)?
Connect Biopharma Holdings Ltd (CNTB)'s trailing twelve month EPS is $-1.10 as of 2026-06-30.
What is CNTB's ROE (return on equity)?
Connect Biopharma Holdings Ltd (CNTB)'s trailing twelve month Return on Equity (ROE) is -140.51% as of 2026-06-30.
What is CNTB's ROA (return on assets)?
Connect Biopharma Holdings Ltd (CNTB)'s trailing twelve month Return on Assets (ROA) is -109.34% as of 2026-06-30.
What is CNTB's ROIC (return on invested capital)?
Connect Biopharma Holdings Ltd (CNTB)'s trailing twelve month Return on Invested Capital (ROIC) is -661.05% as of 2025-12-31.
What is CNTB's EV/EBITDA?
Connect Biopharma Holdings Ltd (CNTB)'s trailing twelve month EV/EBITDA is -1.76x as of 2026-06-30.